Last $58.34 USD
Change Today -0.24 / -0.41%
Volume 8.3M
As of 8:04 PM 03/3/15 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for merck & co. inc. (MRK)

Year over year, Merck & Co. Inc. has seen revenues shrink from $44.0B USD to $42.2B USD, though the company was able to grow net income from $4.4B USD to $11.9B USD. A reduction in the percentage of sales devoted to cost of goods sold from 36.29% to 35.95% was a key component in the bottom line growth in the face of falling revenues.
Currency in
Millions of US Dollars
As of:Dec 31
2011
Reclassified
Dec 31
2012
Reclassified
Dec 31
2013
Reclassified
Dec 31
2014
4 Year
Trend
Revenues48,047.047,267.044,033.042,237.0
TOTAL REVENUES48,047.047,267.044,033.042,237.0
Cost of Goods Sold16,316.016,258.015,981.015,186.0
GROSS PROFIT31,731.031,009.028,052.027,051.0
Selling General & Admin Expenses, Total13,336.012,686.011,766.011,406.0
R&D Expenses7,742.07,911.07,115.06,532.0
OTHER OPERATING EXPENSES, TOTAL21,078.020,597.018,881.017,938.0
OPERATING INCOME10,653.010,412.09,171.09,113.0
Interest Expense-695.0-714.0-801.0-732.0
Interest and Investment Income145.0232.0264.0266.0
NET INTEREST EXPENSE-550.0-482.0-537.0-466.0
Income (Loss) on Equity Investments610.0642.0404.0257.0
Currency Exchange Gains (Loss)-143.0-185.0-150.0-180.0
Other Non-Operating Income (Expenses)-23.031.0-27.0873.0
EBT, EXCLUDING UNUSUAL ITEMS10,547.010,418.08,861.09,597.0
Merger & Restructuring Charges-2,278.0-999.0-2,401.0-1,978.0
Impairment of Goodwill-------93.0
Gain (Loss) on Sale of Investments143.013.039.0-43.0
Gain (Loss) on Sale of Assets127.0----11,893.0
Other Unusual Items, Total-1,205.0-693.0-954.0-2,093.0
Legal Settlements---493.0----
Other Unusual Items-500.0---148.0-944.0
EBT, INCLUDING UNUSUAL ITEMS7,334.08,739.05,545.017,283.0
Income Tax Expense942.02,440.01,028.05,349.0
Minority Interest in Earnings-120.0-131.0-113.0-14.0
Earnings from Continuing Operations6,392.06,299.04,517.011,934.0
NET INCOME6,272.06,168.04,404.011,920.0
NET INCOME TO COMMON INCLUDING EXTRA ITEMS6,257.06,165.04,404.011,920.0
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS6,257.06,165.04,404.011,920.0
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MRK:US $58.34 USD -0.24

MRK Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Gilead Sciences Inc $102.79 USD -1.04
GlaxoSmithKline PLC 1,545 GBp -6.00
Pfizer Inc $34.56 USD -0.21
Roche Holding AG SFr.261.90 CHF +1.90
Sanofi €86.29 EUR +0.13
View Industry Companies
 

Industry Analysis

MRK

Industry Average

Valuation MRK Industry Range
Price/Earnings 14.4x
Price/Sales 4.0x
Price/Book 3.4x
Price/Cash Flow 13.9x
TEV/Sales 3.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MERCK & CO. INC., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.